As of November 6, 2026, Harmony Biosciences Holdings, Inc. is a publicly traded company (Nasdaq: HRMY); its largest reported holder is BlackRock, with 12.6% on Schedule 13G/A of October 27, 2026, then Fidelity (FMR) (5.4%). The largest insider holding is Marshman Fund Trust II, a 10% owner, with 6,051,120 shares (10.3% of shares outstanding), per Form 4 of November 5, 2024 (Schedule 13G/A, October 27, 2026).
Is this your company?
About to sign with, pay or invest in Harmony Biosciences Holdings, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Harmony Biosciences Holdings, Inc. a real, registered company?
- Harmony Biosciences Holdings, Inc. files with the SEC under CIK 1802665 (its SEC filings).
- Its shares are listed under the ticker HRMY on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Plymouth Meeting, Pennsylvania, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Harmony Biosciences Holdings, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Peter Anastasiou, President and Chief Executive Officer (Form 8-K filed 2026-10-30). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names BlackRock (filed 2026-10-27).
Who are Harmony Biosciences Holdings, Inc.'s owners and officers?
Harmony Biosciences Holdings, Inc.: incorporated in Delaware; business address in Plymouth Meeting, Pennsylvania; industry Pharmaceutical Preparations (Form D, 2026-10-30).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-10-27 | Blackrock, Inc. | 12.6% |
| Schedule 13G, 2026-07-31 | Vanguard Portfolio Management | 5.08% |
| Schedule 13G/A, 2026-07-28 | Blackrock, Inc. | 11.3% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G/A, 2026-02-05 | Fmr LLC | 5.4% |
| Schedule 13G/A, 2025-11-14 | Antonio J. Gracias | 3.2% |
| Schedule 13G/A, 2025-11-05 | Fmr LLC | 6.7% |
Questions about who owns Harmony Biosciences Holdings, Inc.
Who owns Harmony Biosciences Holdings, Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Harmony Biosciences Holdings, Inc.: Blackrock, Inc. (12.6%, Schedule 13G/A, filed 2026-10-27), Fmr LLC (5.4%, Schedule 13G/A, filed 2026-02-05) and Vanguard Portfolio Management (5.08%, Schedule 13G, filed 2026-07-31).
Who are the largest shareholders of Harmony Biosciences Holdings, Inc.?
By the share each holder's latest filing reports, the largest holders of Harmony Biosciences Holdings, Inc. on this page are Blackrock, Inc. (12.6%), Fmr LLC (5.4%) and Vanguard Portfolio Management (5.08%).
When did Blackrock, Inc. buy into Harmony Biosciences Holdings, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Blackrock, Inc. on this page is the Schedule 13G/A, filed 2026-07-28, reporting 11.3%; its latest, Schedule 13G/A filed 2026-10-27, reports 12.6%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Harmony Biosciences Holdings, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Harmony Biosciences Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Harmony Biosciences Holdings, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
16 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-10-30 | Peter Anastasiou | President and Chief Executive Officer | appointed | 2027-01-01 |
| Form 8-K, 2026-10-13 | Peter Anastasiou | President and Chief Executive Officer | appointed | 2027-01-01 |
| Form 8-K, 2026-07-16 | Stephen Mollichella | Principal Financial Officer | appointed | 2026-07-16 |
| Form 8-K, 2026-04-14 | Glenn Reicin | Chief Financial Officer | appointed | 2026-04-14 |
| Form 8-K, 2026-04-02 | Antonio Gracias | Director | departed |
Which insiders own Harmony Biosciences Holdings, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Marshman Fund Trust II, a 10% owner: 6,051,120 shares (10.3% of shares outstanding) (Form 4, 2024-11-05).
- , the chief financial officer: 24,521 shares (0.04% of shares outstanding) (Form 4, 2026-01-28).
- Valor Management L.P., a 10% owner: 23,714 shares (0.04% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2025-09-02).
- Valor Equity Partners Iv-a L.P., a 10% owner: 23,714 shares (0.04% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2025-09-02).
- Valor Equity Partners IV L.P., a 10% owner: 23,714 shares (0.04% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2025-09-02).
Shares outstanding: 58,723,199 as of 2026-11-02, from the company's latest SEC cover page.
How much has Harmony Biosciences Holdings, Inc. raised?
No fundraising or offering filing from Harmony Biosciences Holdings, Inc. is on file with us.
Keep reading
More on Harmony Biosciences Holdings, Inc. and the records around it.
Harmony Biosciences Holdings, Inc. elsewhere on the record
- Leadership changes Jul 2026
Companies that share a holder
- FMR LLC also filed stake reports on 761 other companies: ASPEN NEUROSCIENCE INC (Nov 2026), AVALO THERAPEUTICS INC (Nov 2026), BRAZE INC (Nov 2026)
- Vanguard Portfolio Management also filed stake reports on 941 other companies: Newmark Group Inc (Nov 2026), A10 Networks Inc (Oct 2026), ADT Inc (Oct 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/harmony-biosciences